Download the admit cards and issue printed copies to students Once students receive their admit cards, they must verify every detail printed on them without delay. The hall ticket should clearly ...

CISCE Class 10th, 12th Hall Ticket 2026: The Council for Indian School Certificate Examinations (CISCE) has released the ISC Class 12th Admit Card 2026 and the ICSE Hall Ticket 2026. As per reports, ...

The Council for the Indian School Certificate Examinations (CISCE) has officially issued the admit cards for the ICSE Class 10 and ISC Class 12 board examinations 2026. Schools affiliated with the ...

ICSE, ISC Exam Admit Card 2026: The Council for the Indian School Certificate Examinations (CISCE) is expected to release the Indian Certificate of Secondary Education (ICSE) (Class 10) and Indian ...

The Council for the Indian School Certificate Examinations (CISCE) has introduced a new subject, entrepreneurship, at the ISC level from exam year 2028. In a circular issued to principals on Friday, ...

The CISCE will soon release ICSE Class 10th and ISC Class 12 exam 2026 admit cards. With exams starting on February 17th for Class 10th and February 12th for Class 12th, the admit cards are expected ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...